Profil
Jackson Brougher has founded Doloromics, Inc. in 2020 and currently holds the title of Chief Scientific Officer.
Postes actifs de Jackson Brougher
Sociétés | Poste | Début |
---|---|---|
Doloromics, Inc.
Doloromics, Inc. BiotechnologyHealth Technology Doloromics, Inc. is a spin-out company from the University of Texas at . Doloromics is based in Dallas, TX. The company aims to achieve this goal through two main approaches, which involve bringing disease-modifying, precision treatments to patients who are underserved by the current status quo. It was founded in 2020 by four neuroscience researchers with the goal of improving chronic pain treatments. The company was founded in 2020 by Ted Price, Candler Paige, Jackson Brougher. Candler Paige has been the CEO since 2020. | Fondateur | 01/01/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Doloromics, Inc.
Doloromics, Inc. BiotechnologyHealth Technology Doloromics, Inc. is a spin-out company from the University of Texas at . Doloromics is based in Dallas, TX. The company aims to achieve this goal through two main approaches, which involve bringing disease-modifying, precision treatments to patients who are underserved by the current status quo. It was founded in 2020 by four neuroscience researchers with the goal of improving chronic pain treatments. The company was founded in 2020 by Ted Price, Candler Paige, Jackson Brougher. Candler Paige has been the CEO since 2020. | Health Technology |